The assessment of cysteinyl leukotriene receptor antagonist role in inhibition of atherosclerosis, proliferation and its influence on endothelial function in patients undergoing endovascular treatment due to peripheral arterial disease.
2019/33/B/NZ5/00609
Keywords
Descriptors
- NZ5_003: Patogeneza chorób człowieka
- NZ5_007: Leczenie chorób człowieka
Panel
NZ5 – Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution
Uniwersytet Jagielloński, Collegium Medicum
Voivodeship: małopolskie
Principal investigator (from the host institution)
Number of co-investigators in the project: 7
Call
OPUS 17 – announced on 2019-03-15
- Amount awarded
- 1 745 600 PLN
- Project start date
- 2020-05-04
- Project end date
- 2026-12-03
- Project duration
- 79 months (the same as in the proposal)
- Project status
- Pending project
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.